☰

Michael Sela - Publications

Affiliations: 
Chemical Immunology Weizmann Institute of Science, Rehovot, Israel 
Area:
peptide and protein chemistry and immunology
Website:
http://www.inbevbailletlatour.com/media/misc_media/CV_Michael_Sela1.pdf
Tree Info Similar researchers PubMed Report error

274 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Maron R, Schechter B, Nataraj NB, Ghosh S, Romaniello D, Marrocco I, Noronha A, Carvalho S, Yarden Y, Sela M. Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies. Biochemical and Biophysical Research Communications. PMID 30952434 DOI: 10.1016/J.Bbrc.2019.03.204  0.336
2019 Sela M. Molecular genetics of antibody formation Report of a Colloquium held during the 7th FEBS Meeting, Varna, Bulgaria, 20-25 September 1971. Febs Letters. 19: 181-185. PMID 11946207 DOI: 10.1016/0014-5793(71)80509-4  0.321
2019 Sela M. Antibodies: Shape, homogeneity, and valency. Febs Letters. 1: 83-85. PMID 11945260 DOI: 10.1016/0014-5793(68)80025-0  0.353
2016 Carvalho S, Levi-Schaffer F, Sela M, Yarden Y. Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review X. British Journal of Pharmacology. PMID 26833433 DOI: 10.1111/Bph.13450  0.385
2015 Yarden Y, Sela M. Cancer Immunotherapy: More Is (Much) Better. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 4030-2. PMID 26019173 DOI: 10.1158/1078-0432.Ccr-15-0996  0.334
2015 Gaborit N, Abdul-Hai A, Mancini M, Lindzen M, Lavi S, Leitner O, Mounier L, Chentouf M, Dunoyer S, Ghosh M, Larbouret C, Chardès T, Bazin H, Pèlegrin A, Sela M, et al. Examination of HER3 targeting in cancer using monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America. 112: 839-44. PMID 25564668 DOI: 10.1073/Pnas.1423645112  0.327
2013 Kohavi D, Badihi L, Rosen G, Steinberg D, Sela MN. An in vivo method for measuring the adsorption of plasma proteins to titanium in humans. Biofouling. 29: 1215-24. PMID 24088083 DOI: 10.1080/08927014.2013.834332  0.356
2013 Maron R, Schechter B, Mancini M, Mahlknecht G, Yarden Y, Sela M. Inhibition of pancreatic carcinoma by homo-and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2 Proceedings of the National Academy of Sciences of the United States of America. 110: 15389-15394. PMID 24003140 DOI: 10.1073/Pnas.1313857110  0.345
2013 Ferraro DA, Gaborit N, Maron R, Cohen-Dvashi H, Porat Z, Pareja F, Lavi S, Lindzen M, Ben-Chetrit N, Sela M, Yarden Y. Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR Proceedings of the National Academy of Sciences of the United States of America. 110: 1815-1820. PMID 23319610 DOI: 10.1073/Pnas.1220763110  0.331
2011 Witsch EJ, Mahlknecht G, Wakim J, Sertchook R, Bublil E, Yarden Y, Sela M. Generation and characterization of peptide mimotopes specific for anti erbb-2 monoclonal antibodies International Immunology. 23: 391-403. PMID 21602175 DOI: 10.1093/Intimm/Dxr028  0.384
2011 Emde A, Pradeep CR, Ferraro DA, Ben-Chetrit N, Sela M, Ribba B, Kam Z, Yarden Y. Combining epitope-distinct antibodies to HER2: Cooperative inhibitory effects on invasive growth Oncogene. 30: 1631-1642. PMID 21132012 DOI: 10.1038/Onc.2010.547  0.339
2009 Ben-Kasus T, Schechter B, Lavi S, Yarden Y, Sela M. Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis Proceedings of the National Academy of Sciences of the United States of America. 106: 3294-3299. PMID 19218427 DOI: 10.1073/Pnas.0812059106  0.37
2009 Schechter B, Ben-Kasus T, Yarden Y, Sela M. On the notion of synergy of monoclonal antibodies as drugs Communicative and Integrative Biology. 2: 477-478. DOI: 10.4161/Cib.2.6.9326  0.365
2007 Ben-Kasus T, Schechter B, Sela M, Yarden Y. Cancer therapeutic antibodies come of age: Targeting minimal residual disease Molecular Oncology. 1: 42-54. PMID 19383286 DOI: 10.1016/J.Molonc.2007.01.003  0.352
2006 Ben-David H, Aruna BV, Seger R, Sela M, Mozes E. A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses Proceedings of the National Academy of Sciences of the United States of America. 103: 18232-18237. PMID 17108079 DOI: 10.1073/Pnas.0608896103  0.344
2006 Aruna BV, Ben-David H, Sela M, Mozes E. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis Immunology. 118: 413-424. PMID 16827902 DOI: 10.1111/J.1365-2567.2006.02398.X  0.341
2006 Sela M. Immunomodulatory vaccines against autoimmune diseases Rejuvenation Research. 9: 126-133. PMID 16608409 DOI: 10.1089/Rej.2006.9.126  0.335
2005 Ben-David H, Sela M, Moses E. Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis Proceedings of the National Academy of Sciences of the United States of America. 102: 2028-2033. PMID 15677327 DOI: 10.1073/Pnas.0409549102  0.315
2004 Sela M, Mozes E. Therapeutic vaccines in autoimmunity Proceedings of the National Academy of Sciences of the United States of America. 101: 14586-14592. PMID 15308777 DOI: 10.1073/Pnas.0404826101  0.364
2004 Dayan M, Sthoeger Z, Neiman A, Abarbanel J, Sela M, Mozes E. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis Human Immunology. 65: 571-577. PMID 15219376 DOI: 10.1016/J.Humimm.2004.02.030  0.327
2004 Sela M, Fuchs S, Maron R, Gertner B. Dose response and induction of tolerance to the synthetic antigen (T,G)-A-L in adult rabbits. European Journal of Immunology. 1: 36-9. PMID 14978860 DOI: 10.1002/Eji.1830010107  0.349
2003 Arnon R, Sela M. Immunomodulation by the Copolymer Glatiramer Acetate Journal of Molecular Recognition. 16: 412-421. PMID 14732933 DOI: 10.1002/Jmr.628  0.306
2003 Teitelbaum D, Brenner T, Abramsky O, Aharoni R, Sela M, Arnon R. Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy Multiple Sclerosis. 9: 592-599. PMID 14664472 DOI: 10.1191/1352458503Ms963Oa  0.337
2003 Sela M. From proteins and protein models to their use in immunology and immunotherapy Journal of Biological Chemistry. 278: 48507-48519. PMID 13679360 DOI: 10.1074/Jbc.X300007200  0.355
2003 Paas-Rozner M, Sela M, Mozes E. A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells Proceedings of the National Academy of Sciences of the United States of America. 100: 6676-6681. PMID 12743364 DOI: 10.1073/Pnas.1131898100  0.312
2002 Sela M. A polymer as an active ingredient in a drug - The development of copolymer 1 as a drug against multiple sclerosis Polymers For Advanced Technologies. 13: 859-862. DOI: 10.1002/Pat.239  0.301
2001 Paas-Rozner M, Sela M, Mozes E. The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes. Proceedings of the National Academy of Sciences of the United States of America. 98: 12642-7. PMID 11606745 DOI: 10.1073/Pnas.221456798  0.336
2001 Brenner T, Arnon R, Sela M, Abramsky O, Meiner Z, Riven-Kreitman R, Tarcik N, Teitelbaum D. Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone. Journal of Neuroimmunology. 115: 152-60. PMID 11282165 DOI: 10.1016/S0165-5728(01)00250-8  0.381
2001 Faber-Elmann A, Grabovsky V, Dayan M, Sela M, Alon R, Mozes E. An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 187-194. PMID 11149906 DOI: 10.1096/Fj.99-0976Com  0.353
2000 Vaisman N, Nissim A, Klapper LN, Tirosh B, Yarden Y, Sela M. Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library. Immunology Letters. 75: 61-7. PMID 11163868 DOI: 10.1016/S0165-2478(00)00278-9  0.413
2000 Faber-Elmann A, Grabovsky V, Dayan M, Sela M, Alon R, Mozes E. Cytokine profile and T cell adhesiveness to endothelial selectins: in vivo induction by a myasthenogenic T cell epitope and immunomodulation by a dual altered peptide ligand. International Immunology. 12: 1651-8. PMID 11099304 DOI: 10.1093/Intimm/12.12.1651  0.33
2000 Hurwitz E, Klapper LN, Wilchek M, Yarden Y, Sela M. Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies. Cancer Immunology, Immunotherapy : Cii. 49: 226-34. PMID 10941905 DOI: 10.1007/S002620000112  0.358
2000 Kipnis J, Yoles E, Porat Z, Cohen A, Mor F, Sela M, Cohen IR, Schwartz M. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proceedings of the National Academy of Sciences of the United States of America. 97: 7446-51. PMID 10861010 DOI: 10.1073/Pnas.97.13.7446  0.309
2000 Sela M. Structural components responsible for peptide antigenicity. Applied Biochemistry and Biotechnology. 83: 63-70; discussion 14. PMID 10826949 DOI: 10.1385/Abab:83:1-3:63  0.33
2000 Paas-Rozner M, Dayan M, Paas Y, Changeux JP, Wirguin I, Sela M, Mozes E. Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice. Proceedings of the National Academy of Sciences of the United States of America. 97: 2168-73. PMID 10681457 DOI: 10.1073/Pnas.040554597  0.347
1999 Sela M. Specific vaccines against autoimmune diseases Comptes Rendus De L'Academie Des Sciences - Serie Iii. 322: 933-938. PMID 10646086 DOI: 10.1016/S0764-4469(00)87189-9  0.37
1999 Sela M. The concept of specific immune treatment against autoimmune diseases International Reviews of Immunology. 18: 201-216. PMID 10614724 DOI: 10.3109/08830189909043025  0.345
1999 Teitelbaum D, Arnon R, Sela M. Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1 Proceedings of the National Academy of Sciences of the United States of America. 96: 3842-3847. PMID 10097125 DOI: 10.1073/Pnas.96.7.3842  0.304
1999 Aharoni R, Teitelbaum D, Arnon R, Sela M. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking Proceedings of the National Academy of Sciences of the United States of America. 96: 634-639. PMID 9892685 DOI: 10.1073/Pnas.96.2.634  0.367
1998 SELA M, KATCHALSKI E. Biological properties of poly-alpha-amino acids. Advances in Protein Chemistry. 14: 391-478. PMID 14444673 DOI: 10.1016/S0065-3233(08)60614-2  0.321
1998 SELA M, ARNON R. Studies on the chemical basis of the antigenicity of proteins. 1. Antigenicity of polypeptidyl gelatins. The Biochemical Journal. 75: 91-102. PMID 14444672 DOI: 10.1042/Bj0750091  0.36
1998 SELA M, ARNON R. A specific synthetic polypeptide antigen. Biochimica Et Biophysica Acta. 40: 382-4. PMID 14444671 DOI: 10.1016/0006-3002(60)91377-9  0.376
1998 SELA M, FUCHS S, FELDMAN M. Specific immunologic unresponsiveness to synthetic polypeptide antigens. Science (New York, N.Y.). 139: 342-3. PMID 13992691 DOI: 10.1126/Science.139.3552.342  0.378
1998 SELA M, FUCHS S, ARNON R. Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine. The Biochemical Journal. 85: 223-35. PMID 13992690 DOI: 10.1042/Bj0850223  0.345
1998 ARNON R, SELA M. Isolation of antibodies to gelatin from antigen-antibody complex by proteolysis. Science (New York, N.Y.). 132: 86-7. PMID 13794395 DOI: 10.1126/Science.132.3419.86  0.395
1998 SELA M, ARNON R. Studies on the chemical basis of the antigenicity of proteins. 3. The role of rigidity in the antigenicity of polypeptidyl gelatins. The Biochemical Journal. 77: 394-9. PMID 13749856 DOI: 10.1042/Bj0770394  0.357
1998 Aharoni R, Teitelbaum D, Sela M, Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1 Journal of Neuroimmunology. 91: 135-146. PMID 9846830 DOI: 10.1016/S0165-5728(98)00166-0  0.339
1998 Faber-Elmann A, Paas-Rozner M, Sela M, Mozes E. Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes Proceedings of the National Academy of Sciences of the United States of America. 95: 14320-14325. PMID 9826698 DOI: 10.1073/Pnas.95.24.14320  0.342
1998 Katz-Levy Y, Dayan M, Wirguin I, Fridkin M, Sela M, Mozes E. Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis Journal of Neuroimmunology. 85: 78-86. PMID 9627000 DOI: 10.1016/S0165-5728(97)00265-8  0.324
1997 Aharoni R, Teitelbaum D, Sela M, Arnon R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis Proceedings of the National Academy of Sciences of the United States of America. 94: 10821-10826. PMID 9380718 DOI: 10.1073/Pnas.94.20.10821  0.3
1997 Aharoni R, Schlegel PG, Teitelbaum D, Roikhel-Karpov O, Chen Y, Arnon R, Sela M, Chao NJ. Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease Immunology Letters. 58: 79-87. PMID 9271317 DOI: 10.1016/S0165-2478(97)00032-1  0.314
1997 Teitelbaum D, Arnon R, Sela M. Cop 1 as a candidate drug for multiple sclerosis Journal of Neural Transmission, Supplement. 85-91. PMID 9266417 DOI: 10.1007/978-3-7091-6844-8_9  0.305
1997 Fridkis-Hareli M, Teitelbaum D, Pecht I, Arnon R, Sela M. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells International Immunology. 9: 925-934. PMID 9237101 DOI: 10.1093/Intimm/9.7.925  0.379
1997 Sela M, Zisman E. Different roles of D-amino acids in immune phenomena Faseb Journal. 11: 449-456. PMID 9194525 DOI: 10.1096/Fasebj.11.6.9194525  0.383
1997 Klapper LN, Vaisman N, Hurwitz E, Pinkas-Kramarski R, Yarden Y, Sela M. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors Oncogene. 14: 2099-2109. PMID 9160890 DOI: 10.1038/Sj.Onc.1201029  0.341
1997 Teitelbaum D, Arnon R, Sela M. Copolymer 1: From basic research to clinical application Cellular and Molecular Life Sciences. 53: 24-28. PMID 9117994 DOI: 10.1007/Pl00000576  0.343
1997 Katz-Levy Y, Paas-Rozner M, Kirshner S, Dayan M, Zisman E, Fridkin M, Wirguin I, Sela M, Mozes E. A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses Proceedings of the National Academy of Sciences of the United States of America. 94: 3200-3205. PMID 9096370 DOI: 10.1073/Pnas.94.7.3200  0.359
1997 Kami A, Zisman E, Katz-Levy Y, Paas-Rozner M, Dayan M, Brautbar C, Abramsky O, Sela M, Mozes E. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor Neurology. 48: 1638-1642. DOI: 10.1212/Wnl.48.6.1638  0.337
1997 Aharoni R, Teitelbaum D, Arnon R, Sela M. 2-31-01 Copolymer 1 inhibits the response to myelin basic protein p84-102 by T cell receptor antagonism in addition to MHC blocking Journal of the Neurological Sciences. 150: S115-S116. DOI: 10.1016/S0022-510X(97)85412-3  0.303
1996 SELA M, FUCHS S. A SYNTHETIC POLYPEPTIDE ANTIGEN DEVOID OF CHARGE. Biochimica Et Biophysica Acta. 74: 796-8. PMID 14078950 DOI: 10.1016/0006-3002(63)91438-0  0.304
1996 Arnon R, Sela M, Teitelbaum D. New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis Journal of Neurology, Supplement. 243: S8-S13. PMID 8965119 DOI: 10.1007/Bf00873696  0.371
1996 Ben-Nun A, Mendel I, Bakimer R, Fridkis-Hareli M, Teitelbaum D, Arnon R, Sela M, Kerlero de Rosbo N. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: Effect of copolymer 1 on MOG-induced disease Journal of Neurology. 243: S14-S22. PMID 8965116 DOI: 10.1007/Bf00873697  0.31
1996 Kirshner SL, Zisman E, Fridkin M, Sela M, Mozes E. Altered peptide ligands of a myasthenogenic epitope as modulators of specific T-cell responses Scandinavian Journal of Immunology. 44: 512-521. PMID 8947604 DOI: 10.1046/J.1365-3083.1996.D01-330.X  0.343
1996 Sela M, Pecht I. The nature of the antigen Advances in Protein Chemistry. 49: 289-328. PMID 8908301 DOI: 10.1016/S0065-3233(08)60492-1  0.416
1996 Schlegel PG, Aharoni R, Chen Y, Chen J, Teitelbaum D, Arnon R, Sela M, Chao NJ. A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo Proceedings of the National Academy of Sciences of the United States of America. 93: 5061-5066. PMID 8643529 DOI: 10.1073/Pnas.93.10.5061  0.354
1996 Zisman E, Katz-Levy Y, Dayan M, Kirshner SL, Paas-Rozner M, Karni A, Abramskyi O, Brautbar C, Fridkin M, Sela M, Mozes E. Peptide analogs to pathogenic epitopes of the human acetylcholine receptor a subunit as potential modulators of myasthenia gravis Proceedings of the National Academy of Sciences of the United States of America. 93: 4492-4497. PMID 8633096 DOI: 10.1073/Pnas.93.9.4492  0.329
1996 Teitelbaum D, Fridkis-Hareli M, Arnon R, Sela M. Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses Journal of Neuroimmunology. 64: 209-217. PMID 8632064 DOI: 10.1016/0165-5728(95)00180-8  0.347
1995 Zisman E, Brautbar C, Sela M, Abramsky O, Battat S, Kirshner SL, Katz-Levy Y, Dayan M, Mozes E. Binding of peptides of the human acetylcholine receptor α-subunit to HLA class II of patients with myasthenia gravis Human Immunology. 44: 121-130. PMID 8666548 DOI: 10.1016/0198-8859(95)00094-1  0.32
1995 Tawfik DS, Chap R, Green BS, Sela M, Eshhar Z. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: Is there a linkage to autoimmunity? Proceedings of the National Academy of Sciences of the United States of America. 92: 2145-2149. PMID 7892238 DOI: 10.1073/Pnas.92.6.2145  0.365
1995 Hurwitz E, Stancovski I, Sela M, Yarden Y. Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake Proceedings of the National Academy of Sciences of the United States of America. 92: 3353-3357. PMID 7724565 DOI: 10.1073/Pnas.92.8.3353  0.366
1995 Fridkis-Hareli M, Teitelbaum D, Arnon R, Sela M. Synthetic copolymer 1 and myelin basic protein do not require processing prior to binding to class II major histocompatibility complex molecules on living antigen-presenting cells Cellular Immunology. 163: 229-236. PMID 7541725 DOI: 10.1006/Cimm.1995.1121  0.328
1994 Zisman E, Sela M, Ben-Nun A, Mozes E. Dichotomy between the T and the B cell epitopes of the synthetic polypeptide (T,G)-A--L. European Journal of Immunology. 24: 2497-505. PMID 7523144 DOI: 10.1002/Eji.1830241036  0.301
1994 Fridkis-Hareli M, Teitelbaum D, Gurevich E, Pecht I, Brautbar C, Kwon OJ, Brenner T, Arnon R, Sela M. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity. Proceedings of the National Academy of Sciences of the United States of America. 91: 4872-6. PMID 7515181 DOI: 10.1073/Pnas.91.11.4872  0.364
1993 Zisman E, Dayan M, Sela M, Mozes E. Ia-antigen-T-cell interactions for a thymus-independent antigen composed of D amino acids. Proceedings of the National Academy of Sciences of the United States of America. 90: 994-8. PMID 8381541 DOI: 10.1073/Pnas.90.3.994  0.37
1993 Muszkat KA, Schechter B, Sela M. Aromatic side-chain interactions as the origin of immunological diversity in the TyrTyrGluGlu and TyrGluTyrGlu epitopes: NMR and fluorescence evidence. International Immunology. 5: 591-7. PMID 7688560 DOI: 10.1093/Intimm/5.6.591  0.334
1993 Katz-Levy Y, Kirshner SL, Sela M, Mozes E. Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs Proceedings of the National Academy of Sciences of the United States of America. 90: 7000-7004. PMID 7688469 DOI: 10.1073/Pnas.90.15.7000  0.331
1993 Tawfik DS, Green BS, Chap R, Sela M, Eshhar Z. catELISA: A facile general route to catalytic antibodies Proceedings of the National Academy of Sciences of the United States of America. 90: 373-377. PMID 7678455 DOI: 10.1073/Pnas.90.2.373  0.337
1993 Sela M. Polymeric drugs as immunomodulatory vaccines against multiple sclerosis Macromolecular Symposia. 70: 147-155. DOI: 10.1002/Masy.19930700117  0.34
1992 Hurwitz E, Adler R, Shouval D, Takahashi H, Wands JR, Sela M. Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice. Cancer Immunology, Immunotherapy. 35: 186-192. PMID 1638555 DOI: 10.1007/Bf01756186  0.365
1992 Muszkat KA, Schechter B, Sela M. Structural origin of the immunological diversity of two closely related tetrapeptides: CIDNP study of TyrTyrGluGlu and TyrGluTyrGlu epitopes. Molecular Immunology. 29: 1049-54. PMID 1379676 DOI: 10.1016/0161-5890(92)90036-W  0.368
1992 Teitelbaum D, Milo R, Arnon R, Sela M. Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein. Proceedings of the National Academy of Sciences of the United States of America. 89: 137-41. PMID 1370347 DOI: 10.1073/Pnas.89.1.137  0.343
1992 Stancovski I, Peles E, Ben Levy R, Lemprecht R, Kelman Z, Goldman-Michael R, Hurwitz E, Bacus S, Sela M, Yarden Y. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy. The Journal of Steroid Biochemistry and Molecular Biology. 43: 95-103. PMID 1356018 DOI: 10.1016/0960-0760(92)90192-L  0.337
1991 Zisman E, Sela M, Mozes E. Direct binding of a synthetic multichain polypeptide to class II major histocompatibility complex molecules on antigen-presenting cells and stimulation of a specific T-cell line require processing of the polypeptide. Proceedings of the National Academy of Sciences of the United States of America. 88: 9738-9742. PMID 1946395 DOI: 10.1073/Pnas.88.21.9738  0.374
1991 Teitelbaum D, Aharoni R, Sela M, Arnon R. Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. Proceedings of the National Academy of Sciences of the United States of America. 88: 9528-32. PMID 1719533 DOI: 10.1073/Pnas.88.21.9528  0.405
1991 Stancovski I, Hurwitz E, Leitner O, Ullrich A, Yarden Y, Sela M. Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth Proceedings of the National Academy of Sciences of the United States of America. 88: 8691-8695. PMID 1717984 DOI: 10.1073/Pnas.88.19.8691  0.368
1991 Teitelbaum D, Milo R, Arnon R, Sela M. Specific inhibition by the synthetic copolymer COP-1 of human T cell lines specific to myelin basic protein Journal of Neuroimmunology. 35: 72. DOI: 10.1016/0165-5728(91)90970-I  0.302
1990 Hurwitz E, Stancovski I, Wilchek M, Shouval D, Takahashi H, Wands JR, Sela M. A conjugate of 5-fluorouridine-poly(L-lysine) and an antibody reactive with human colon carcinoma. Bioconjugate Chemistry. 1: 285-90. PMID 2096921 DOI: 10.1021/Bc00004A010  0.416
1990 Galun E, Shouval D, Adler R, Shahaar M, Wilchek M, Hurwitz E, Sela M. The effect of anti-alpha-fetoprotein-adriamycin conjugate on a human hepatoma. Hepatology (Baltimore, Md.). 11: 578-84. PMID 1691730 DOI: 10.1002/Hep.1840110409  0.37
1989 Aboud-Pirak E, Hurwitz E, Pirak ME, Bellot F, Schlessinger J, Sela M. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. Journal of the National Cancer Institute. 80: 1605-11. PMID 3193478 DOI: 10.1093/Jnci/80.20.1605  0.374
1989 Aboud-Pirak E, Hurwitz E, Bellot F, Schlessinger J, Sela M. Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor. Proceedings of the National Academy of Sciences of the United States of America. 86: 3778-81. PMID 2786202 DOI: 10.1073/Pnas.86.10.3778  0.365
1989 Teitelbaum D, Aharoni R, Arnon R, Sela M. Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1. Proceedings of the National Academy of Sciences of the United States of America. 85: 9724-8. PMID 2462252 DOI: 10.1073/Pnas.85.24.9724  0.357
1988 Shouval D, Adler R, Wands JR, Hurwitz E, Isselbacher KJ, Sela M. Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens Proceedings of the National Academy of Sciences of the United States of America. 85: 8276-8280. PMID 2460865 DOI: 10.1073/Pnas.85.21.8276  0.406
1987 Jacob CO, Arnon R, Sela M. Anti-cholera response elicited by a completely synthetic antigen with built-in adjuvanticity administered in aqueous solution. Immunology Letters. 14: 43-8. PMID 3804383 DOI: 10.1016/0165-2478(86)90018-0  0.404
1986 Jacob CO, Grossfeld S, Sela M, Arnon R. Priming immune response to cholera toxin induced by synthetic peptides. European Journal of Immunology. 16: 1057-62. PMID 3758153 DOI: 10.1002/Eji.1830160905  0.363
1986 Jacob CO, Harari I, Arnon R, Sela M. Antibodies to cholera toxin synthetic peptides of increasing size and their reactivity with related toxins Vaccine. 4: 95-98. PMID 3727761 DOI: 10.1016/0264-410X(86)90045-9  0.351
1986 Jacob CO, Arnon R, Sela M. Effect of carrier on the immunogenic capacity of synthetic cholera vaccine. Molecular Immunology. 22: 1333-9. PMID 2421153 DOI: 10.1016/0161-5890(85)90054-9  0.362
1985 Jacob CO, Sela M, Pines M, Hurwitz S, Arnon R. Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides. Proceedings of the National Academy of Sciences of the United States of America. 81: 7893-6. PMID 6595665 DOI: 10.1073/Pnas.81.24.7893  0.354
1985 Hurwitz E, Kashi R, Arnon R, Wilchek M, Sela M. The covalent linking of two nucleotide analogues to antibodies Journal of Medicinal Chemistry. 28: 137-140. PMID 2578191 DOI: 10.1002/Chin.198521345  0.37
1984 Sela M. From synthetic antigens to synthetic vaccines. Biopolymers. 22: 415-24. PMID 6673767 DOI: 10.1002/Bip.360220155  0.391
1984 Jacob CO, Sela M, Arnon R. Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin. Proceedings of the National Academy of Sciences of the United States of America. 80: 7611-5. PMID 6584874 DOI: 10.1073/Pnas.80.24.7611  0.36
1984 Sela M, Arnon R. Synthetic Antigens and Vaccines Interdisciplinary Science Reviews. 9: 175-185. DOI: 10.1007/978-1-4757-0283-5_18  0.313
1983 Bahr GM, Eshhar Z, Ben-Yitzhak R, Modabber FZ, Arnon R, Sela M, Chedid L. Monoclonal antibodies to the synthetic adjuvant muramyl dipeptide: characterization of the specificity. Molecular Immunology. 20: 745-52. PMID 6888382 DOI: 10.1016/0161-5890(83)90052-4  0.422
1983 Parhami-Seren B, Mozes E, Sela M. Fine specificity of antibodies to the synthetic polypeptide poly(L-tyrosine, L-glutamic acid)-poly(DL-alanine)--poly(L-lysine) and its ordered analogs as followed by solid-phase radioimmunoassay. Archives of Biochemistry and Biophysics. 225: 446-50. PMID 6194752 DOI: 10.1016/0003-9861(83)90052-8  0.305
1983 Tsukada Y, Hurwitz E, Kashi R, Sela M, Hibi N, Hara A, Hirai H. Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies. Proceedings of the National Academy of Sciences of the United States of America. 79: 7896-9. PMID 6185954 DOI: 10.1073/Pnas.79.24.7896  0.36
1982 Arnon R, Sela M. In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies. Immunological Reviews. 62: 5-27. PMID 7042540 DOI: 10.1111/J.1600-065X.1982.Tb00387.X  0.34
1982 Parhami-Seren B, Strassmann G, Mozes E, Sela M. Cellular analysis of specificity of antibodies and of delayed type hypersensitivity responses toward some structurally related synthetic antigens: boosting is determined by specificity of T cells. Proceedings of the National Academy of Sciences of the United States of America. 79: 5636-40. PMID 6982473 DOI: 10.1073/Pnas.79.18.5636  0.341
1982 Audibert F, Jolivet M, Chedid L, Arnon R, Sela M. Successful immunization with a totally synthetic diphtheria vaccine. Proceedings of the National Academy of Sciences of the United States of America. 79: 5042-6. PMID 6956913 DOI: 10.1073/Pnas.79.16.5042  0.363
1981 Arnon R, Sela M, Parant M, Chedid L. Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity. Proceedings of the National Academy of Sciences of the United States of America. 77: 6769-72. PMID 6935684 DOI: 10.1073/Pnas.77.11.6769  0.363
1981 Mozes E, Sela M, Chedid L. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine). Proceedings of the National Academy of Sciences of the United States of America. 77: 4933-7. PMID 6776530 DOI: 10.1073/Pnas.77.8.4933  0.366
1980 Pilz I, Schwarz E, Durchschein W, Light A, Sela M. Effect of cleaving interchain disulfide bridges on the radius of gyration and maximum length of anti-poly(D-alanyl) antibodies before and after reaction with tetraalanine hapten. Proceedings of the National Academy of Sciences of the United States of America. 77: 117-21. PMID 6767235 DOI: 10.1073/Pnas.77.1.117  0.373
1980 Arnon R, Hurwitz E, Sela M. Antibodies as carriers for oncostatic materials Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 75: 236-245. PMID 6165055 DOI: 10.1007/978-3-642-81491-4_37  0.384
1980 Forster HK, Sela M. Conformational changes induced in anti-poly(L-prolyl) antibodies by oligoproline haptens of different sizes. Molecular Immunology. 16: 651-6. PMID 530276 DOI: 10.1016/0161-5890(79)90004-X  0.362
1979 Hurwitz E, Schechter B, Arnon R, Sela M. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastases. In vitro and in vivo studies with Lewis lung carcinoma International Journal of Cancer. 24: 461-470. PMID 393637 DOI: 10.1002/Ijc.2910240414  0.303
1979 Schwartz M, Parhami B, Mozes E, Sela M. Change in specificity of antibodies to a random synthetic branched polypeptide in mice tolerant to its ordered analogs. Proceedings of the National Academy of Sciences of the United States of America. 76: 5286-8. PMID 291946 DOI: 10.1073/Pnas.76.10.5286  0.388
1978 Hurwitz E, Maron R, Arnon R, Wilchek M, Sela M. Daunomycin-immunoglobulin conjugates, uptake and activity in vitro European Journal of Cancer (1965). 14: 1213-1220. PMID 738327 DOI: 10.1016/0014-2964(78)90227-X  0.324
1978 Hurwitz E, Maron R, Bernstein A, Wilchek M, Sela M, Arnon R. The effect in vivo of chemotherapeutic drug--antibody conjugates in two murine experimental tumor systems. International Journal of Cancer. 21: 747-55. PMID 669855 DOI: 10.1002/Ijc.2910210612  0.337
1978 Schwartz M, Lancet D, Mozes E, Sela M. Affinity and avidity of antibodies to the random polymer (T,G)-A--L and a related ordered synthetic polypeptide. Immunochemistry. 15: 477-81. PMID 81802 DOI: 10.1016/0161-5890(78)90077-9  0.377
1977 Schmitt-Verhulst AM, Mozes E, Sela M. Analysis of the role of different cell types in the genetic regulation of antibody production to the thymus-independent synthetic polypeptide poly (DTyr, DGlu)-poly (DPro)--poly (DLys). European Journal of Immunology. 5: 496-501. PMID 1086247 DOI: 10.1002/Eji.1830050713  0.404
1977 Teitelbaum D, Steinman L, Sela M. Unprimed spleen cell populations recognize macrophage-bound antigen with opposite net electric charge. Proceedings of the National Academy of Sciences of the United States of America. 74: 1693-6. PMID 300877 DOI: 10.1073/Pnas.74.4.1693  0.341
1977 Langbeheim H, Arnon R, Sela M. Antiviral effect on MS-2 coliphage obtained with a synthetic antigen. Proceedings of the National Academy of Sciences of the United States of America. 73: 4636-40. PMID 63950 DOI: 10.1073/Pnas.73.12.4636  0.311
1976 Schwartz M, Hooghe RJ, Mozes E, Sela M. Role of antigenic structure in cell to cell cooperation Proceedings of the National Academy of Sciences of the United States of America. 73: 4184-4186. PMID 1087024 DOI: 10.1073/Pnas.73.11.4184  0.382
1976 Oppenheim JJ, Mozes E, Sela M. In vitro proliferative reactions by lymphocytes from both responder and "low" responder mice to (T,G)-A--L. Advances in Experimental Medicine and Biology. 66: 261-6. PMID 1083637 DOI: 10.1007/978-1-4613-4355-4_39  0.319
1976 Arnon R, Bustin M, Calef E, Chaitchik S, Haimovich J, Novik N, Sela M. Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera. Proceedings of the National Academy of Sciences of the United States of America. 73: 2123-7. PMID 1064879 DOI: 10.1073/Pnas.73.6.2123  0.39
1976 Cramer M, Schwartz M, Mozes E, Sela M. Reconstitution of genetically regulated responses against random and ordered synthetic polypeptides by methylated bovine serum albumin as analyzed by isoelectric focusing European Journal of Immunology. 6: 618-623. PMID 1001360 DOI: 10.1002/Eji.1830060905  0.32
1976 Sela M, Mozes E. Varied effects of polyadenylic-polyuridylic acid on immune responses. Biochimie. 58: 173-7. PMID 953051 DOI: 10.1016/S0300-9084(76)80367-7  0.372
1976 Schwartz M, Waltenbaugh C, Dorf M, Cesla R, Sela M, Benacerraf B. Determinants of antigenic molecules responsible for genetically controlled regulation of immune responses. Proceedings of the National Academy of Sciences of the United States of America. 73: 2862-6. PMID 60762 DOI: 10.1073/Pnas.73.8.2862  0.33
1976 Webb C, Teitelbaum D, Herz A, Arnon R, Sela M. Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids. Immunochemistry. 13: 333-7. PMID 59690 DOI: 10.1016/0019-2791(76)90344-X  0.318
1976 Schwartz M, Mozes E, Sela M. Genetic control of the immune response to ordered peptides of tyrosine and glutamic acid Advances in Experimental Medicine and Biology. 66: 545-546. PMID 57708 DOI: 10.1007/978-1-4613-4355-4_84  0.375
1975 Bonavida B, Mozes E, Shearer GM, Sela M. Immunological unresponsiveness induced in adult mice to synthetic polypeptides built on multichain polyproline and multichain polyalanine. Immunochemistry. 11: 347-53. PMID 4142448 DOI: 10.1016/0019-2791(74)90187-6  0.353
1975 Falkenberg FW, Sulica A, Shearer GM, Mozes E, Sela M. Cellular analysis of the phenotypic correction of the genetically controlled low immune response to the polyproline determinant by macrophages. Cellular Immunology. 12: 271-9. PMID 4142419 DOI: 10.1016/0008-8749(74)90079-3  0.321
1975 Pilz I, Kratky O, Licht A, Sela M. Shape and volume of fragments Fab' and (Fab')2 of anti-poly(D-alanyl) antibodies in the presence and absence of tetra-D-alanine as determined by small-angle x-ray scattering. Biochemistry. 14: 1326-33. PMID 1168070 DOI: 10.1021/Bi00677A035  0.335
1975 Matthyssens GE, Hurwitz E, Givol D, Sela M. Binding of histamine- and other ligand-conjugated macromolecules to lymphocytes Molecular and Cellular Biochemistry. 7: 119-126. PMID 1143285 DOI: 10.1007/Bf01792078  0.343
1975 Teitelbaum D, Webb C, Rauch H, Karniely Y, Arnon R, Sela M. Inverse relationship between net electric charge on the antigen and that on the sensitized cell in cellular immune response: demonstration with basic encephalitogen of the brain. The Journal of Experimental Medicine. 142: 701-8. PMID 51899 DOI: 10.1084/Jem.142.3.701  0.333
1975 Jormalainen S, Mozes E, Sela M. Genetic control of immune response. The dose of antigen given in aqueous solution is critical in determining which mouse strain is high responder to poly(LTyr, LGlu)-poly(LPro)--poly(LLys). The Journal of Experimental Medicine. 141: 1057-72. PMID 47893 DOI: 10.1084/Jem.141.5.1057  0.323
1975 Schwartz M, Mozes E, Sela M. Genetically controlled immune responses of inbred mouse strains to conjugates of the ordered peptides (Tyr-Tyr-Glu-Glu) and (Tyr-Glu-Tyr-Glu) with multichain poly-DL-alanine as compared with the response to the random (T, G)-A--L European Journal of Immunology. 5: 866-871. DOI: 10.1002/Eji.1830051212  0.388
1974 Levin H, Becker M, Sela M. Antigenicity of p-azobenzenearsonate-containing oligopeptides in rabbits. European Journal of Biochemistry. 44: 271-8. PMID 4850606 DOI: 10.1111/J.1432-1033.1974.Tb03482.X  0.441
1974 Teitelbaum D, Arnon R, Sela M, Rabinsohn Y, Shapiro D. Sphingomyelin specific antibodies elicited by synthetic conjugates. Immunochemistry. 10: 735-43. PMID 4767007 DOI: 10.1016/0019-2791(73)90175-4  0.399
1974 Fuchs S, Aharonov A, Sela M, von der Haar F, Cramer F. Antibodies to yeast phenylalanine transfer ribonucleic acid are specific for the odd nucleoside ) in the anticodon loop. Proceedings of the National Academy of Sciences of the United States of America. 71: 2800-2. PMID 4527666 DOI: 10.1073/Pnas.71.7.2800  0.374
1974 Mozes E, Shaltiel S, Sela M. The genetic control of the immune response to different antigenic determinants within the synthetic polypeptide poly(His, Glu)-polyPro-polyLys. European Journal of Immunology. 4: 463-7. PMID 4137977 DOI: 10.1002/Eji.1830040704  0.34
1974 Mozes E, Shearer GM, Sela M. Genetic control and immunity. Advances in Experimental Medicine and Biology. 31: 145-65. PMID 4136748 DOI: 10.1007/978-1-4684-3225-1_11  0.322
1974 Mozes E, Schwartz M, Sela M. Antibody response of inbred mouse strains to ordered tetrapeptides of tyrosine and glutamic acid attached to multichain polyalanine or polyproline. Tyr tyr Glu Glu is a major determinant of the random poly (Tyr, Glu) polydlAla polyLys Journal of Experimental Medicine. 140: 349-355. PMID 4136183 DOI: 10.1084/Jem.140.2.349  0.334
1974 Mozes E, Sela M. The role of the thymus in a genetically controlled defect of the immune response at the carrier level. Proceedings of the National Academy of Sciences of the United States of America. 71: 1574-7. PMID 4133852 DOI: 10.1073/Pnas.71.4.1574  0.349
1974 Aharonov A, Fuchs S, Stollar BD, Sela M. Immunogenicity and antigenic specificity of a glutaraldehyde cross-linked transfer RNA-protein conjugate. European Journal of Biochemistry. 42: 73-9. PMID 4133788 DOI: 10.1111/J.1432-1033.1974.Tb03316.X  0.375
1974 Fuchs S, Mozes E, Maoz A, Sela M. Thymus independence of a collagen like synthetic polypeptide and of collagen, and the need for thymus and bone marrow cell cooperation in the immune response to gelatin Journal of Experimental Medicine. 139: 148-158. PMID 4128446 DOI: 10.1084/Jem.139.1.148  0.351
1974 Webb C, Teitelbaum D, Arnon R, Sela M. In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis. European Journal of Immunology. 3: 279-86. PMID 4128128 DOI: 10.1002/Eji.1830030506  0.33
1974 Teitelbaum D, Webb C, Meshorer A, Arnon R, Sela M. Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen. European Journal of Immunology. 3: 273-9. PMID 4128127 DOI: 10.1002/Eji.1830030505  0.325
1974 Schmitt-Verhulst A-, Mozes E, Sela M. Genetic control of the immune response to a thymus independent synthetic polypeptide Immunogenetics. 1: 357-369. DOI: 10.1007/Bf01564074  0.373
1973 Taussig MJ, Mozes E, Shearer GM, Sela M. Studies on the mechanism of antigenic competition: analysis of competition between synthetic polypeptide antigens. European Journal of Immunology. 2: 448-52. PMID 5084396 DOI: 10.1002/Eji.1830020513  0.306
1973 Pilz I, Kratky O, Licht A, Sela M. Shape and volume of anti-poly(D-alanyl) antibodies in the presence and absence of tetra-D-alanine as followed by small-angle x-ray scattering. Biochemistry. 12: 4998-5005. PMID 4796922 DOI: 10.1021/Bi00748A028  0.343
1973 Maoz A, Dym H, Fuchs S, Sela M. Cytotoxic activity of antibodies to a collagen‐like synthetic polytripeptide on cells in tissue culture European Journal of Immunology. 3: 839-842. PMID 4781395 DOI: 10.1002/Eji.1830031219  0.308
1973 Maoz A, Fuchs S, Sela M. On immunological cross-reactions between the synthetic ordered polypeptide (L-Pro-Gly-L-Pro)n and several collagens Biochemistry. 12: 4246-4252. PMID 4745670 DOI: 10.1021/Bi00745A032  0.332
1973 Mozes E, Sela M, McDevitt HO. Genetic control of immune response in mice to derivatives of multichain polyproline differing in the optical configuration of component amino acids. European Journal of Immunology. 3: 1-6. PMID 4717930 DOI: 10.1002/Eji.1830030102  0.386
1973 Gurari D, Ungar-Waron H, Sela M. Antigenicity of dinitrophenyl polyproline. European Journal of Immunology. 3: 196-200. PMID 4716492 DOI: 10.1002/Eji.1830030404  0.408
1973 Dray F, Maron E, Tillson SA, Sela M. Immunochemical detection of prostaglandins with prostaglandin-coated bacteriophage T 4 and by radioimmunoassay. Analytical Biochemistry. 50: 399-408. PMID 4674976 DOI: 10.1016/0003-2697(72)90048-6  0.319
1973 Levin S, Altman Y, Nir E, Hurwitz E, Sela M. Penicillin antibodies and immunoglobulin production in newborn infants: Studies with chemically modified bacteriophage Pediatric Research. 7: 675-683. PMID 4581539 DOI: 10.1203/00006450-197308000-00001  0.324
1973 Ungar Waron H, Gurari D, Hurwitz E, Sela M. Role of a rigid polyproline spacer inserted between hapten and carrier in the induction of anti hapten antibodies and delayed hypersensitivity European Journal of Immunology. 3: 201-205. PMID 4577409 DOI: 10.1002/Eji.1830030405  0.417
1973 Fuchs S, Sela M, Anfinsen CB. Nuclease-coated bacteriophage: a sensitive tool for studying antigenic reactivity of synthetic sequence fragments. Archives of Biochemistry and Biophysics. 154: 601-5. PMID 4570842 DOI: 10.1016/0003-9861(73)90014-3  0.58
1973 Bustin M, Tarrab R, Strausbauch PH, Sulica A, Sela M. Stimulation of anti-hapten response by heterologous protein devoid of hapten. European Journal of Immunology. 2: 288-90. PMID 4569173 DOI: 10.1002/Eji.1830020319  0.345
1973 Shearer GM, Melmon KL, Weinstein Y, Sela M. Regulation of antibody response by cells expressing histamine receptors. The Journal of Experimental Medicine. 136: 1302-7. PMID 4563150 DOI: 10.1084/Jem.136.5.1302  0.339
1973 Taussig MJ, Mozes E, Shearer GM, Sela M. Antigenic competition and genetic control of the immune response. A hypothesis for intramolecular competition. Cellular Immunology. 8: 299-310. PMID 4542157 DOI: 10.1016/0008-8749(73)90119-6  0.393
1973 Maoz A, Fuchs S, Sela M. Immune response to the collagen-like synthetic ordered polypeptide (L-Pro-Gly-L-Pro)n Biochemistry. 12: 4238-4245. PMID 4355557 DOI: 10.1021/Bi00745A031  0.384
1973 Arnon R, Teicher E, Bustin M, Sela M. Preparation of antisera to alpha-fetoprotein making use of estradiol affinity column. Febs Letters. 32: 335-8. PMID 4354823 DOI: 10.1016/0014-5793(73)80867-1  0.355
1973 Bonavida B, Fuchs S, Sela M. Nucleoside-coated bacteriophage T4: a method for the detection and characterization of anti-nucleoside antibodies. Journal of Immunological Methods. 1: 155-64. PMID 4342925 DOI: 10.1016/0022-1759(72)90042-7  0.386
1973 Taussig MJ, Mozes E, Shearer GM, Sela M. Cooperation of antigenic determinants in intact mice and interference by antigenic competition. European Journal of Immunology. 2: 577-81. PMID 4120279 DOI: 10.1002/Eji.1830020619  0.323
1973 Teitelbaum D, Webb C, Meshorer A, Arnon R, Sela M. Protection against experimental allergic encephalomyelitis. Nature. 240: 564-6. PMID 4119624 DOI: 10.1038/240564B0  0.304
1973 Bustin M, Eshhar Z, Sela M. Characterization and partial purification of antigenic components solubilized by a reversible chemical modification from rat-thymocyte membrane. European Journal of Biochemistry. 31: 541-53. PMID 4119486 DOI: 10.1111/J.1432-1033.1972.Tb02563.X  0.323
1973 Becker MJ, Levin H, Sela M. The specificity of cellular immunity: studies in guinea pigs using defined tetrapeptides containing p‐azobenzenearsonate‐L‐tyrosine European Journal of Immunology. 3: 131-135. DOI: 10.1002/Eji.1830030304  0.368
1972 Teitelbaum D, Meshorer A, Hirshfeld T, Arnon R, Sela M. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. European Journal of Immunology. 1: 242-8. PMID 5157960 DOI: 10.1002/Eji.1830010406  0.316
1972 Sulica A, Tarrab R, Haimovich J, Sela M. Effect of phytohemagglutinin on thymidine incorporation and antibody production in the secondary response in vitro towards a defined hapten. European Journal of Immunology. 1: 236-8. PMID 5157959 DOI: 10.1002/Eji.1830010404  0.382
1972 Pecht I, Givol D, Sela M. Dynamics of hapten-antibody interaction. Studies on a myeloma protein with anti-2, 4-dinitrophenyl specificity Journal of Molecular Biology. 68: 241-247. PMID 5069790 DOI: 10.1016/0022-2836(72)90211-2  0.356
1972 Tarrab R, Sulica A, Haimovich J, Sela M. Cell proliferation and antibody production in the secondary response in vitro towards a defined hapten. European Journal of Immunology. 1: 231-6. PMID 4945683 DOI: 10.1002/Eji.1830010403  0.375
1972 Gurari D, Bonavida B, Taussig MJ, Fuchs S, Sela M. Use of immunologically modified bacteriophage T4 in detection of antibodies to nucleic acids. European Journal of Biochemistry. 26: 247-50. PMID 4558243 DOI: 10.1111/J.1432-1033.1972.Tb01762.X  0.389
1972 Bonavida B, Fuchs S, Sela M, Roddy PW, Sober HA. Specific antibodies to dinucleotides and trinucleotides. European Journal of Biochemistry. 31: 534-40. PMID 4119485 DOI: 10.1111/J.1432-1033.1972.Tb02562.X  0.379
1972 Sela M, Mozes E, Shearer GM. Thymus-independence of slowly metabolized immunogens. Proceedings of the National Academy of Sciences of the United States of America. 69: 2696-700. PMID 4115955 DOI: 10.1073/Pnas.69.9.2696  0.386
1972 Shearer GM, Mozes E, Sela M. Contribution of different cell types to the genetic control of immune responses as a function of the chemical nature of the polymeric side chains (poly-L-prolyl and poly-DL-alanyl) of synthetic immunogens. The Journal of Experimental Medicine. 135: 1009-27. PMID 4112259 DOI: 10.1084/Jem.135.5.1009  0.336
1972 Licht A, Schechter B, Sela M. Antibodies against polyalanyl determinants attached to negatively or positively charged carriers. European Journal of Immunology. 1: 351-9. PMID 4110257 DOI: 10.1002/Eji.1830010510  0.374
1972 Sela M. Effect of antigenic structure on antibody biosynthesis. Annals of the New York Academy of Sciences. 190: 181-202. PMID 4109639 DOI: 10.1111/J.1749-6632.1971.Tb13534.X  0.379
1972 Shearer GM, Mozes E, Sela M. Cellular basis of the genetic control of immune responses to synthetic polypeptides. II. Frequency of immunocompetent precursors specific for two distinct regions within (Phe, G)-Pro--L, a synthetic polypeptide derived from multichain polyproline, in inbred mouse strains. The Journal of Experimental Medicine. 133: 216-30. PMID 4109112 DOI: 10.1084/Jem.133.2.216  0.333
1972 Shaltiel S, Mozes E, Sela M. Multichain Polyproline Coated with Histidyl and Glutamyl Residues - A Potent Synthetic Immunogen Israel Journal of Chemistry. 10: 627-633. DOI: 10.1002/Ijch.197200060  0.364
1971 Sulica A, Tarrab R, Sela M. Stimulation in vitro with protein carrier of antibodies against a hapten. Science (New York, N.Y.). 171: 1165-7. PMID 5544874 DOI: 10.1126/Science.171.3976.1165  0.398
1971 Mozes E, Shearer GM, Sela M. Cellular basis of the genetic control of immune responses to synthetic polypeptides. I. Differences in frequency of splenic precursor cells specific for a synthetic polypeptide derived from multichain polyproline ((T,G)-Pro--L) in high and low responder inbred mouse strains. The Journal of Experimental Medicine. 132: 613-22. PMID 5534158 DOI: 10.1084/Jem.132.4.613  0.36
1971 Becker MJ, Conway-Jacobs A, Wilchek M, Haimovich J, Sela M. Detection of anti-p-azobenzenearsonate antibodies with chemically modified bacteriophage. Immunochemistry. 7: 741-3. PMID 5488034 DOI: 10.1016/0019-2791(70)90180-1  0.344
1971 Schechter B, Conway-Jacobs A, Sela M. Conformational changes in a synthetic antigen induced by specific antibodies. European Journal of Biochemistry. 20: 321-4. PMID 5314317 DOI: 10.1111/J.1432-1033.1971.Tb01396.X  0.387
1971 Arnon R, Maron E, Sela M, Anfinsen CB. Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. Proceedings of the National Academy of Sciences of the United States of America. 68: 1450-5. PMID 5283934 DOI: 10.1073/Pnas.68.7.1450  0.6
1971 Sela M, Mozes E, Shearer GM, Karniely Y. Cellular aspects of the inverse relationship between the net charge of immunogens of antibodies elicited. Proceedings of the National Academy of Sciences of the United States of America. 67: 1288-93. PMID 5274458 DOI: 10.1073/Pnas.67.3.1288  0.406
1971 Inouye H, Fuchs S, Sela M, Littauer UZ. Anti-inosine antibodies. Biochimica Et Biophysica Acta. 240: 594-603. PMID 5166308 DOI: 10.1016/0005-2787(71)90717-9  0.41
1971 Pecht I, Maron E, Arnon R, Sela M. Specific Excitation Energy Transfer from Antibodies to Dansyl‐Labeled Antigen Febs Journal. 19: 368-371. PMID 5102921 DOI: 10.1111/J.1432-1033.1971.Tb01325.X  0.36
1971 Eshhar Z, Gafni M, Givol D, Sela M. Solubilization of lymphocyte and thymocyte antigens by a reversible chemical modification European Journal of Immunology. 1: 323-329. PMID 4945634 DOI: 10.1002/Eji.1830010504  0.376
1971 Bonavida B, Fuchs S, Sela M. Antibodies to transfer RNA obtained with covalently linked tRNA conjugates. Biochemical and Biophysical Research Communications. 41: 1335-41. PMID 4921760 DOI: 10.1016/0006-291X(70)90235-4  0.314
1971 Shaltiel S, Mizrahi R, Sela M. On the immunological properties of penicillins. Proceedings of the Royal Society of London. Series B, Biological Sciences. 179: 411-32. PMID 4401419 DOI: 10.1098/Rspb.1971.0106  0.387
1971 Tarrab R, Schechter I, Sela M. Antibody response to polyalanyl determinants in tolerant rabbits. Immunochemistry. 8: 1107-15. PMID 4113504 DOI: 10.1016/0019-2791(71)90390-9  0.356
1971 Sela M. On Antibody Formation to Defined Determinants International Archives of Allergy and Immunology. 41: 180-185. PMID 4104665 DOI: 10.1159/000230516  0.368
1971 Conway-Jacobs A, Schechter B, Sela M. A comparison of the antigenic specificity of random and ordered linear polypeptides composed of L-tyrosine, L-alanine and L-glutamic acid. European Journal of Biochemistry. 20: 325-9. PMID 4103321 DOI: 10.1111/J.1432-1033.1971.Tb01397.X  0.323
1971 Melchers F, Sela M. Search for antibodies against the carbohydrate portion of two mouse myeloma proteins. Immunochemistry. 7: 749-54. PMID 4099597 DOI: 10.1016/0019-2791(70)90217-X  0.372
1971 Bonavida B, Fuchs S, Inouye H, Sela M. Inosine-coated bacteriophage T4 Biochimica Et Biophysica Acta (Bba) - Nucleic Acids and Protein Synthesis. 240: 604-610. DOI: 10.1016/0005-2787(71)90718-0  0.384
1970 Shaltiel S, Mizrahi R, Stupp Y, Sela M. Reduction in immunological manifestations of 6-aminopenicillanic acid by treatment with water-insoluble pronase. European Journal of Biochemistry. 14: 509-15. PMID 5479379 DOI: 10.1111/J.1432-1033.1970.Tb00317.X  0.334
1970 Segal S, Globerson A, Feldman M, Haimovich J, Sela M. In vitro induction of a primary response to the dinitrophenyl determinant. The Journal of Experimental Medicine. 131: 93-9. PMID 5460614 DOI: 10.1084/Jem.131.1.93  0.382
1970 Haimovich J, Hurwitz E, Novik N, Sela M. Preparation of protein-bacteriophage conjugates and their use in detection of anti-protein antibodies Bba - Protein Structure. 207: 115-124. PMID 5444107 DOI: 10.1016/0005-2795(70)90141-8  0.357
1970 Sela M. Antigens and antigenicity. Die Naturwissenschaften. 56: 206-11. PMID 5360102 DOI: 10.1007/Bf01166815  0.354
1970 Sela M. Structure and specificity of synthetic polypeptide antigens. Annals of the New York Academy of Sciences. 169: 23-35. PMID 5263841 DOI: 10.1111/J.1749-6632.1970.Tb55965.X  0.343
1970 Hurwitz E, Dietrich FM, Sela M. A sensitive technique for detecting and estimating the peptide hormone angiotensin-II-beta-amide and its antibodies by using chemically modified bacteriophage and activated sepharose European Journal of Biochemistry. 17: 273-277. PMID 4322652 DOI: 10.1111/J.1432-1033.1970.Tb01164.X  0.376
1970 Scott DW, Waksman BH, Bauminger S, Sela M. Induction of tolerance to poly-dl-alanyl ribonuclease in adult rats Immunochemistry. 7: 357-362. PMID 4246997 DOI: 10.1016/0019-2791(70)90238-7  0.3
1970 Mozes E, McDevitt HO, Jaton JC, Sela M. The genetic control of antibody specificity. The Journal of Experimental Medicine. 130: 1263-78. PMID 4187525 DOI: 10.1084/Jem.130.6.1263  0.347
1970 Schechter B, Schechter I, Sela M. Specific fractionation of antibodies to peptide determinants. Immunochemistry. 7: 587-97. PMID 4098590 DOI: 10.1016/0019-2791(70)90279-X  0.376
1969 Borek F, Kurtz J, Sela M. Immunological properties of a collagen-like synthetic polypeptide. Biochimica Et Biophysica Acta. 188: 314-23. PMID 5823027 DOI: 10.1016/0005-2795(69)90081-6  0.373
1969 Haimovich J, Schechter I, Sela M. Combining sites of IgG and IgM antibodies of poly-D-alanyl specificity. European Journal of Biochemistry / Febs. 7: 537-43. PMID 5813322 DOI: 10.1111/J.1432-1033.1969.Tb19641.X  0.387
1969 Mozes E, McDevitt HO, Jaton JC, Sela M. The nature of the antigenic determinant in a genetic control of the antibody response. The Journal of Experimental Medicine. 130: 493-504. PMID 5807278 DOI: 10.1084/Jem.130.3.493  0.364
1969 Segal S, Givol D, Sela M. Disc electrophoresis patterns of the Fd fragment of rabbit immunoglobulin fractions and of purified antibodies Immunochemistry. 6. PMID 5778777 DOI: 10.1016/0019-2791(69)90159-1  0.365
1969 Haimovich J, Sela M. Protein-bacteriophage conjugates: application in detection of antibodies and antigens. Science (New York, N.Y.). 164: 1279-80. PMID 5770618 DOI: 10.1126/Science.164.3885.1279  0.363
1969 Arnon R, Sela M. Antibodies to a unique region in lysozyme provoked by a synthetic antigen conjugate. Proceedings of the National Academy of Sciences of the United States of America. 62: 163-70. PMID 5253653 DOI: 10.1073/Pnas.62.1.163  0.399
1969 Sela M. Antigenicity: some molecular aspects. Science (New York, N.Y.). 166: 1365-74. PMID 4900368 DOI: 10.1126/Science.166.3911.1365  0.326
1968 McDevitt HO, Sela M. Genetic control of the antibody response. II. Further analysis of the specificity of determinant-specific control, and genetic analysis of the response to (H,G)-A--L in CBA and C57 mice. The Journal of Experimental Medicine. 126: 969-78. PMID 6062007 DOI: 10.1084/Jem.126.5.969  0.375
1968 Haimovich J, Sela M, Dewdney JM, Batchelor FR. Anti-penicilloyl antibodies: detection with penicilloylated bacteriophage and isolation with a specific immunoadsorbent. Nature. 214: 1369-70. PMID 6060648 DOI: 10.1038/2141369A0  0.363
1968 Ernst ML, Arnon R, Sela M. Cleavage of horse immunoglobulin by cyanogen bromide. Immunochemistry. 5: 513-24. PMID 5702350 DOI: 10.1016/0019-2791(68)90088-8  0.386
1968 Acher R, Chauvet J, Arnon R, Sela M. [Preparation and preoperties of poly-DL-alanyl derivatives of a trypsin inhibitor Kunitz and Northrop inhibitor)]. European Journal of Biochemistry. 3: 476-82. PMID 5689276 DOI: 10.1111/J.1432-1033.1967.Tb19555.X  0.31
1968 Rüde E, Mozes E, Sela M. Role of the net electrical charge of the complete antigen in determining the chemical nature of anti-p-azobenzenearsonate antibodies. Biochemistry. 7: 2971-5. PMID 5666764 DOI: 10.1021/Bi00848A038  0.354
1968 Gershon H, Bauminger S, Sela M, Feldman M. Studies on the competence of single cells to produce antibodies of two specificities. The Journal of Experimental Medicine. 128: 223-33. PMID 5662016 DOI: 10.1084/Jem.128.1.223  0.409
1968 Jaton JC, Klinman NR, Givol D, Sela M. Recovery of antibody activity upon reoxidation of completely reduced polyalanyl heavy chain and its fd fragment derived from anti-2,4-dinitrophenyl antibody Biochemistry. 7: 4185-4195. PMID 4973471 DOI: 10.1021/Bi00852A008  0.352
1968 Rnon R, Sela M, Rachaman ES, Shapiro D. Cytolipin H-specific antibodies obtained with a synthetic polypeptide conjugate. European Journal of Biochemistry. 2: 79-83. PMID 4965791 DOI: 10.1111/J.1432-1033.1967.Tb00109.X  0.409
1968 Stupp Y, Sela M. Further studies on the immunogenicity of D-amino acid polymers. Biochimica Et Biophysica Acta. 140: 349-59. PMID 4964462 DOI: 10.1016/0005-2795(67)90475-8  0.365
1968 Jaton JC, Ungar-Waron H, Sela M. Comparison of IgG and IgM antibodies specific for uridine. European Journal of Biochemistry. 2: 106-14. PMID 4169689 DOI: 10.1111/J.1432-1033.1967.Tb00114.X  0.4
1968 Sela M, Ungar-Waron H. [175] Preparation of nucleoside-specific synthetic antigens Methods in Enzymology. 12: 900-903. DOI: 10.1016/0076-6879(67)12209-X  0.428
1967 Ungar-Waron H, Hurwitz E, Jaton JC, Sela M. Antibodies elicited with conjugates of nucleosides with synthetic polypeptides. Biochimica Et Biophysica Acta. 138: 513-31. PMID 6036848 DOI: 10.1016/0005-2787(67)90548-5  0.402
1967 Robbins JB, Haimovich J, Sela M. Purification of antibodies with immunoadsorbents prepared using bromoacetyl cellulose Immunochemistry. 4. PMID 6030410 DOI: 10.1016/0019-2791(67)90192-9  0.411
1967 Ungar-Waron H, Sela M. Pyridoxal-specific antibodies obtained with a synthetic pyridoxal-polypeptide conjugate. Biochimica Et Biophysica Acta. 124: 147-53. PMID 5966707 DOI: 10.1016/0304-4165(66)90322-9  0.407
1967 Moroz C, de Vries A, Sela M. Isolation and characterization of a neurotoxin from Vipera palestinae venom. Biochimica Et Biophysica Acta. 124: 136-46. PMID 5966706 DOI: 10.1016/0304-4165(66)90321-7  0.301
1967 Neumann H, Steinberg IZ, Brown JR, Goldberger RF, Sela M. On the non-essentiality of two specific disulphide bonds in ribonuclease for its biological activity. European Journal of Biochemistry / Febs. 3: 171-82. PMID 5625038 DOI: 10.1111/J.1432-1033.1967.Tb19513.X  0.611
1967 Bauminger S, Schechter I, Sela M. Specificity of immunological tolerance to poly-DL-aalanyl proteins. Immunochemistry. 4: 169-81. PMID 5584605 DOI: 10.1016/0019-2791(67)90126-7  0.307
1967 Sela M. Immunological studies with synthetic polypeptides. Advances in Immunology. 5: 29-129. PMID 5332821 DOI: 10.1016/S0065-2776(08)60272-2  0.409
1967 Sela M. Chemical studies of the combining sites of antibodies. Proceedings of the Royal Society of London. Series B, Biological Sciences. 166: 188-206. PMID 4382710 DOI: 10.1098/Rspb.1966.0093  0.4
1967 Karush F, Sela M. Equine anti-hapten antibody. IV. The effect of polyalanylation on affinity. Immunochemistry. 4: 259-67. PMID 4166660 DOI: 10.1016/0019-2791(67)90187-5  0.399
1967 Mozes E, Robbins JB, Sela M. Heterogeneity of the light chains of rabbit immunologlobulin G fractions and of a series of antibodies directed towards antigens of deffering complexity Immunochemistry. 4. PMID 4166659 DOI: 10.1016/0019-2791(67)90185-1  0.332
1967 Schechter I, Sela M. Preferential formation of antibodies specific toward D-amino acid residues upon immunization with poly-DL-peptidyl proteins. Biochemistry. 6: 897-905. PMID 4164913 DOI: 10.1021/Bi00855A034  0.394
1967 Lahav M, Arnon R, Sela M. Biological activity of the cleavage product of human immunoglobulin G with cyanogen bromide. The Journal of Experimental Medicine. 125: 787-805. PMID 4164692 DOI: 10.1084/Jem.125.5.787  0.364
1967 Frensdorff A, Wilchek M, Sela M. A Comparative Study of Basic, Acidic and Neutral Polypeptidyl RNases, Including Polyarginyl and Polyhistidyl Derivatives European Journal of Biochemistry. 1: 281-288. DOI: 10.1111/J.1432-1033.1967.Tb00072.X  0.303
1967 Frensdorff A, Sela M. Synthesis, Characterization and Enzymatic Properties of Poly-l-Lysyl Ribonuclease European Journal of Biochemistry. 1: 267-280. DOI: 10.1111/J.1432-1033.1967.Tb00071.X  0.312
1967 Sela M, Schechter B, Schechter I, Borek F. Antibodies to Sequential and Conformational Determinants Cold Spring Harbor Symposia On Quantitative Biology. 32: 537-545. DOI: 10.1101/Sqb.1967.032.01.065  0.359
1967 Robbins JB, Mozes E, Rimon A, Sela M. Correlation between net charge of antigens and electrophoretic mobility of immunoglobulin M antibodies [13] Nature. 213: 1013-1014. DOI: 10.1038/2131013A0  0.389
1966 Schechter I, Schechter B, Sela M. Combining sites of antibodies with L-alanine and D-alanine peptide specificity and the effect of serum proteolytic activity on their estimation. Biochimica Et Biophysica Acta. 127: 438-56. PMID 5964984 DOI: 10.1016/0304-4165(66)90398-9  0.425
1966 Rüde E, Westphal O, Hurwitz E, Fuchs S, Sela M. Synthesis and antigenic properties of sugar-polypeptide conjugates Immunochemistry. 3: 137-151. PMID 5960162 DOI: 10.1016/0019-2791(66)90293-X  0.332
1966 Wilchek M, Frensdorff A, Sela M. New synthesis of poly-L-glutamic acid and poly-L-glutamyl proteins. Archives of Biochemistry and Biophysics. 113: 742-9. PMID 5944974 DOI: 10.1016/0003-9861(66)90257-8  0.318
1966 Borek F, Stupp Y, Fuchs S, Sela M. Relation between optical configuration and immunogenicity of synthetic polypeptides. The Biochemical Journal. 96: 577-82. PMID 5862399 DOI: 10.1042/Bj0960577  0.324
1966 Borek F, Stupp Y, Sela M. Immunogenicity and role of size: response of guinea pigs to oligotyrosine and tyrosine derivatives. Science (New York, N.Y.). 150: 1177-8. PMID 5852973 DOI: 10.1126/Science.150.3700.1177  0.337
1966 McDevitt HO, Sela M. Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. The Journal of Experimental Medicine. 122: 517-31. PMID 5839284 DOI: 10.1084/Jem.122.3.517  0.352
1966 Freedman MH, Slobin LI, Robbins JB, Sela M. Soluble antigen-antibody complexes as intermediates in the purification of antibodies in 8 molar urea Archives of Biochemistry and Biophysics. 116: 82-91. PMID 4960205 DOI: 10.1016/0003-9861(66)90015-4  0.404
1966 Slobin LI, Sela M. Use of urea in the purification of antibodies. Biochimica Et Biophysica Acta. 107: 593-6. PMID 4956212 DOI: 10.1016/0304-4165(65)90202-3  0.359
1966 Sela M, Mozes E. Dependence of the chemical nature of antibodies on the net electrical charge of antigens. Proceedings of the National Academy of Sciences of the United States of America. 55: 445-52. PMID 4161286 DOI: 10.1073/Pnas.55.2.445  0.34
1966 Mozes E, Sela M. Distribution of antibody activities after simultaneous immunization with two antigens Biochimica Et Biophysica Acta (Bba) - General Subjects. 130: 254-256. DOI: 10.1016/0304-4165(66)90031-6  0.373
1965 ARNON R, SELA M, YARON A, SOBER HA. POLYLYSINE-SPECIFIC ANTIBODIES AND THEIR REACTION WITH OLIGOLYSINES. Biochemistry. 4: 948-53. PMID 14337714 DOI: 10.1021/Bi00881A023  0.349
1965 Hurwitz E, Fuchs S, Sela M. On the role of charge in antigen-antibody precipitin reactions Bba - General Subjects. 111: 512-521. PMID 5879484 DOI: 10.1016/0304-4165(65)90061-9  0.382
1965 Schechter I, Sela M. Preferential immune response to D-amino acid residues in poly-DL-amino acid determinants. Biochimica Et Biophysica Acta. 104: 301-2. PMID 5840412 DOI: 10.1016/0304-4165(65)90253-9  0.306
1965 Schechter I, Sela M. Combining sites of antibodies to L-alanine and D-alanine peptide determinants. Biochimica Et Biophysica Acta. 104: 298-300. PMID 5840411 DOI: 10.1016/0304-4165(65)90252-7  0.35
1964 SCHECHTER I, BAUMINGER S, SELA M, NACHTIGAL D, FELDMAN M. IMMUNE RESPONSE TO POLYPEPTIDYL PROTEINS IN RABBITS TOLERANT TO THE PROTEIN CARRIERS. Immunochemistry. 1: 249-65. PMID 14250779 DOI: 10.1016/0019-2791(64)90026-6  0.395
1964 SELA M, UNGAR-WARON H, SHECHTER Y. URIDINE-SPECIFIC ANTIBODIES OBTAINED WITH SYNTHETIC ANTIGENS Proceedings of the National Academy of Sciences of the United States Of. 52: 285-292. PMID 14206592 DOI: 10.1073/Pnas.52.2.285  0.399
1964 Givol D, Sela M. A comparison of fragments of rabbit antibodies and normal γ-globulin by the peptide-map technique Biochemistry. 3: 451-458. PMID 14155112 DOI: 10.1021/Bi00891A025  0.33
1964 Givol D, Sela M. Isolation and fragmentation of antibodies to polytyrosyl gelatin Biochemistry. 3: 444-451. PMID 14155111 DOI: 10.1021/Bi00891A024  0.404
1964 Fuchs S, Sela M. Antigenicity of some new synthetic polypeptides and polypeptidyl gelatins Biochemical Journal. 93: 566-572. PMID 5839191 DOI: 10.1042/Bj0930566  0.337
1963 Sela M, Givol D, Mozes E. Resolution of rabbit γ-globulin into two fractions by chromatography on diethylaminoethyl-sephadex Bba - Biochimica Et Biophysica Acta. 78: 649-657. PMID 14089445 DOI: 10.1016/0006-3002(63)91031-X  0.302
1963 JAGENDORF AT, PATCHORNIK A, SELA M. USE OF ANTIBODY BOUND TO MODIFIED CELLULOSE AS AN IMMUNOSPECIFIC ADSORBENT OF ANTIGENS. Biochimica Et Biophysica Acta. 78: 516-27. PMID 14088781 DOI: 10.1016/0006-3002(63)90913-2  0.622
1963 BROWN RK, TRZPIS MA, SELA M, ANFINSEN CB. STUDIES ON THE ANTIGENIC STRUCTURE OF RIBONUCLEASE. IV. POLYALANYL RIBONUCLEASE. The Journal of Biological Chemistry. 238: 3876-83. PMID 14086720  0.499
1963 COOKE JP, ANFINSEN CB, SELA M. The identification of ureactive amino groups in ribonuclease and their significance to enzymatic activity. The Journal of Biological Chemistry. 238: 2034-9. PMID 14022795  0.458
1963 FUCHS S, SELA M. Studies on the chemical basis of the antigenicity of proteins. 6. Antigenic specificity of some synthetic polypeptides containing tyrosine The Biochemical Journal. 87: 70-79. PMID 13963154 DOI: 10.1042/Bj0870070  0.38
1962 Givol D, Fuchs S, Sela M. Isolation of antibodies to antigens of low molecular weight Bba - Biochimica Et Biophysica Acta. 63: 222-224. PMID 13948303 DOI: 10.1016/0006-3002(62)90362-1  0.344
1962 ANFINSEN CB, SELA M, COOKE JP. The reversible reduction of disulfide bonds in polyalanyl ribonuclease. The Journal of Biological Chemistry. 237: 1825-31. PMID 13861553  0.425
1961 SELA M, STEINBERG IZ, DANIEL E. Optical rotatory properties of poly-L-tryptophan. Biochimica Et Biophysica Acta. 46: 433-40. PMID 13749857 DOI: 10.1016/0006-3002(61)90574-1  0.605
1961 ANFINSEN CB, HABER E, SELA M, WHITE FH. The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. Proceedings of the National Academy of Sciences of the United States of America. 47: 1309-14. PMID 13683522 DOI: 10.1073/Pnas.47.9.1309  0.613
1960 Arnon R, Sela M. Studies on the chemical basis of the antigenicity of proteins. 2. Antigenic specificity of polytyrosyl gelatins. Biochemical Journal. 75: 103-109. PMID 13794396 DOI: 10.1042/Bj0750103  0.365
1960 Steinberg IZ, Harrington WF, Berger A, Sela M, Katchalski E. The Configurational Changes of Poly-L-proline in Solution Journal of the American Chemical Society. 82: 5263-5279. DOI: 10.1021/Ja01505A001  0.592
1960 Steinberg IZ, Harrington WF, Berger A, Sela M, Katchalski E. The configiirational changes of poly-L-proline in solution Journal of the American Chemical Society. 82: 5263-5279.  0.555
1959 SELA M, WHITE FH, ANFINSEN CB. The reductive cleavage of disulfide bonds and its application to problems of protein structure. Biochimica Et Biophysica Acta. 31: 417-26. PMID 13628669 DOI: 10.1016/0006-3002(59)90016-2  0.552
1957 SELA M, ANFINSEN CB, HARRINGTON WF. The correlation of ribonuclease activity with specific aspects of tertiary structure. Biochimica Et Biophysica Acta. 26: 502-12. PMID 13499407 DOI: 10.1016/0006-3002(57)90096-3  0.525
1957 SELA M, ANFINSEN CB. Some spectrophotometric and polarimetric experiments with ribonuclease. Biochimica Et Biophysica Acta. 24: 229-35. PMID 13436418 DOI: 10.1016/0006-3002(57)90186-5  0.471
1957 SELA M, WHITE FH, ANFINSEN CB. Reductive cleavage of disulfide bridges in ribonuclease. Science (New York, N.Y.). 125: 691-2. PMID 13421663 DOI: 10.1126/Science.125.3250.691  0.525
1956 ANFINSEN CB, SELA M, TRITCH H. A method for the specific proteolytic cleavage of protein chains. Archives of Biochemistry and Biophysics. 65: 156-63. PMID 13373415 DOI: 10.1016/0003-9861(56)90184-9  0.559
Show low-probability matches.